Skip to main navigation Skip to search Skip to main content

Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study

  • Christophe Hézode
  • , Gideon M Hirschfield
  • , Wayne Ghesquiere
  • , William Sievert
  • , Maribel Rodriguez-Torres
  • , Stephen D Shafran
  • , Paul J Thuluvath
  • , Harvey A Tatum
  • , Imam Waked
  • , Gamal Esmat
  • , Eric J Lawitz
  • , Vinod K Rustgi
  • , Stanislas Pol
  • , Nina Weis
  • , Paul J Pockros
  • , Marc Bourlière
  • , Lawrence Serfaty
  • , John M Vierling
  • , Michael W Fried
  • , Ola Weiland
    • Maurizia R Brunetto, Gregory T Everson, Stefan Zeuzem, Paul Y Kwo, Mark Sulkowski, Norbert Bräu, Dennis Hernandez, Fiona McPhee, Megan Wind-Rotolo, Zhaohui Liu, Stephanie Noviello, Eric A Hughes, Philip D Yin, Steven Schnittman

Research output: Contribution to journal › Article › peer-review

98 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Daclatasvir plus peginterferon alfa and ribavirin for treatment-naive chronic hepatitis C genotype 1 or 4 infection: a randomised study'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science